同步放化疗与序贯放化疗治疗中晚期食管癌的临床疗效对比

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

同步放化疗与序贯放化疗治疗中晚期食管癌的临床疗效对比梅开
【期刊名称】《中国医学创新》
【年(卷),期】2014(000)002
【摘要】Objective:To compare the effect of concurrent chemoradiotherapy and sequential therapy for advanced esophageal cancer. Method:146 patients with advanced esophageal cancer in our hospital from January 2012 to December 2012 were divided into synchronous group and sequential group according to random number table method,respectively conducted synchronous chemoradiotherapy and sequential chemoradiotherapy. The short-term effect,the 1-year survival rate ,3-year survival rate and toxicity of two groups were observed. Result:The synchronous group efficiency was 69.86%,the sequential group efficiency was 65.75%,the comparison difference of two groups had no statistical significance(P>0.05);1,3-year survival rates of the two groups were compared,the synchronous group were 72.60%,50.68%,the sequential group were 45.20%and 24.66%,the comparison difference of two groups had statistical significance(P<0.05). The synchronization group was significantly better than the sequential group. Conclusion:Compared with sequential therapy, concurrent chemoradiotherapy has a obvious effect in the treatment of advanced esophageal cancer.%目的:比较中晚期食管癌同步放化疗与序贯放化疗的临床治疗效果。

方法:选择2008年6月-2012年12月
本院入住的146例中晚期食管癌患者,按随机数字表法分为同步组与序贯组,分别采用同步放化疗及序贯放化疗。

观察两组患者近期疗效,1、3年生存率及毒副反应。

结果:同步组有效率为69.86%,序贯组为65.75%,两组有效率比较差异无统计学意义(P>0.05);同步组1、3年生存率分别为72.60%、50.68%,序贯组分别为45.20%、24.66%,同步组明显优于序贯组,两组1、3年生存率比较差异均有统计学意义(P<0.05)。

结论:同步放化疗与序贯放化疗治疗中晚期食管癌相比较效果显著。

【总页数】2页(P1-2)
【作者】梅开
【作者单位】南华大学附属第一医院湖南衡阳 421001
【正文语种】中文
【相关文献】
1.同步放化疗与序贯放化疗治疗中晚期食管癌的临床研究 [J], 沈康;肖庆成
2.序贯放化疗与同步放化疗治疗直肠癌的临床疗效对比分析 [J], 李强
3.同步放化疗与序贯放化疗在中晚期食管癌的疗效分析 [J], 陈文玲
4.同步放化疗与序贯放化疗治疗中晚期食管癌的临床研究 [J], 朱晶
5.序贯放化疗与同步放化疗治疗直肠癌的临床疗效对比分析 [J], 李强
因版权原因,仅展示原文概要,查看原文内容请购买。

相关文档
最新文档